跳至主要内容
临床试验/NL-OMON51297
NL-OMON51297招募中4 期

Reduction of blood loss in pediatric osteotomies around the hip - A randomized placebo-controlled trial with tranexamic acid - - TXA-RCT

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 180 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
0 至 17(—)

入选标准

  • The patient population is composed of all patients aged 1-18 years, undergoing
  • a pelvic and/or femoral osteotomy (PFPO) at Erasmus MC-Sophia, for DDH,
  • secondary hip dysplasia, or other indications.
  • In order to be eligible to participate in this study, a subject must meet all
  • of the following criteria:
  • Indication for PFPO
  • Age 1-18 years

排除标准

  • Contra-indication for TXA (active thromboembolic disease, subarachnoidal
  • bleeding, severe renal insufficiency, history of convulsions, disseminated
  • intravascular coagulation)
  • Active use of alternative (anti)fibrinolytics
  • Diagnosed bleeding or coagulation disorder
  • Medical history of thromboembolic complications
  • Insufficient Dutch Language skills of parents/care-takers
  • No informed consent
  • Use of hormonal contraception

研究者

相似试验